Homepage - RS Research

RAISED FUNDS

We raised 2 million Euros from
technology focused venture capital fund
ACT Venture Partners.

GMP CERTIFICATION

Our production facility was
granted GMP license for clinical batch
lyophilized oncology drugs.

CLINICAL TRIALS

In consequence of promising results from
pre-clinical studies, we started
RS-0139’s phase-I clinical trial in NSCLC.

RAISED FUNDS

We raised 12 million USD in our
Series-A investment round from Gen İlaç,
OneLife Ventures and Eczacıbaşı Momentum.